Unlock instant, AI-driven research and patent intelligence for your innovation.

A covalent polypeptide inhibitor targeting PD-L1 and its preparation method and application

A peptide inhibitor, PD-L1 technology, applied in the fields of molecular biology and medicine, can solve the problems of cumbersome preparation of antibody drugs, poor in vitro stability, weak penetration, etc., achieving good research prospects and clinical guiding significance, small molecular weight. , selective effect

Active Publication Date: 2022-02-08
THE NAT CENT FOR NANOSCI & TECH NCNST OF CHINA
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, accurate prediction of tumor response to PD-1 / PD-L1 blockade remains a challenge
[0009] Although antibody drugs have achieved certain immunotherapeutic effects, antibody drugs have problems such as cumbersome preparation, poor in vitro stability, large molecules, difficult labeling, weak penetration, post-translational modification, and high cost, which make them further applied. restricted

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A covalent polypeptide inhibitor targeting PD-L1 and its preparation method and application
  • A covalent polypeptide inhibitor targeting PD-L1 and its preparation method and application
  • A covalent polypeptide inhibitor targeting PD-L1 and its preparation method and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0051] Example 1 Synthesis and Characterization of Covalent Peptide Inhibitor PD-P1

[0052] (1) Experimental instruments and materials

[0053] N-methylmorpholine (NMM), piperidine, trifluoroacetic acid (TFA), dichloromethane (DCM), ninhydrin, vitamin C, phenol, tetramethyluronium hexafluorophosphate (HBTU), hexahydro Pyridine, triisopropylsilane (TIS), ethanedithiol (EDT), N,N dimethylformamide (DMF), anhydrous ether, resin, methanol, various Fmoc protected amino acids, carboxylated tetraphenyl Ethylene (TPE), peptide synthesis tube, shaker, vacuum water pump, rotary evaporator, laser confocal microscope (ZEISS LSM 710), the above reagents and materials were obtained from commercial sources.

[0054] (2) Solvent preparation

[0055]The preparation of the deprotection solvent is hexahydropyridine: N, N dimethylformamide = 1:4

[0056] The preparation of the reaction solution is N-methylmorpholine: N, N dimethylformamide = 1:24

[0057] The lysate was prepared as trifluoro...

Embodiment 2

[0064] Example 2 Self-assembled morphology of polypeptide inhibitor PD-P1 and analysis of its interaction with cells

[0065] (1) Analysis of the assembly morphology of peptide inhibitors by transmission electron microscopy

[0066] The purified PD-P1 polypeptide was placed in ultrapure water with a pH of 6.5, and reacted overnight at a constant temperature of 37°C, and a small amount was placed on a copper grid. After counterstaining with acetate glaze, it was imaged by a transmission electron microscope. The result is as image 3 As shown in a, the results showed that the peptide inhibitor PD-P1 formed nanofibrous structures under acidic conditions.

[0067] (2) Using scanning electron microscope imaging to analyze the interaction between polypeptide inhibitors and tumor cell MC38, the specific method is as follows:

[0068] ①Slide bubble acid (1% HCl, H 2 SO 4 )overnight.

[0069] ② Cleaning: Wash with tap water until colorless, replace tap water with triple distilled ...

Embodiment 3

[0078] Example 3 Analysis of the competition between PD-P1 and PD1 protein at the cellular level

[0079] The colon cancer cell line MC38 was used to verify the competition between PD-P1 and PD1 protein at the cellular level, the specific method is as follows:

[0080] Colon cancer cell line MC38 was cultured in MEM / EBSS medium containing 10% fetal bovine serum. Take 1×10 5 / mL cell concentration into a round glass-bottom Petri dish (35mm), 37 ° C, 5% CO 2 After culturing in the cell incubator for 24 hours, the culture medium was discarded, washed twice with 1×PBS, peptide inhibitors PD-P1 and PD1 protein were added to one dish, and PD1 protein was added to the other dish alone, and after incubation for 45 minutes, pre- Wash with cold 1×PBS for 3 times, block with BSA for 30min, then add streptavidin-labeled FITC dye, and incubate for 30min. ×PBS was washed 3 times, and the fluorescence distribution in the cells was detected with a laser confocal microscope (ZEISS LSM 710)....

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to the technical fields of molecular biology and medicine, in particular to a covalent polypeptide inhibitor targeting PD-L1 and its preparation method and application. The general formula of the covalent polypeptide inhibitor is X-SKDEEWHKNNFPLSPGNTYYEDQG, wherein X is a carboxylated tetraphenylethylene molecule. The covalent polypeptide inhibitor provided by the present invention has extremely high affinity and specificity to PD‑L1, and it can self-assemble to form nanofibers, target tumor cells with high expression of PD‑L1, and can be used as a molecular probe It is suitable for screening patients suitable for immunotherapy and evaluating the curative effect. It can also be used as a targeting polypeptide for targeted therapy and imaging of tumors with high expression of PD‑L1, and has good application and promotion value.

Description

technical field [0001] The invention relates to the technical fields of molecular biology and medicine, in particular to a covalent polypeptide inhibitor targeting programmed death ligand-1 (PD-L1) and its preparation method and application. Background technique [0002] In recent years, with the rapid development and mutual penetration of related disciplines such as oncology, immunology, and molecular biology, the research and development of tumor immunotherapy has been advancing by leaps and bounds. Tumor immunotherapy has become a new and important anti-tumor treatment. Different from previous surgical treatment, chemical drug treatment, radiotherapy and targeted therapy, tumor immunotherapy is a treatment that activates the body's own immune system to fight against tumors, and has become a new hope for conquering malignant tumors. The core of tumor immunotherapy is to activate the anti-tumor response of T lymphocytes in tumor patients to improve their killing function a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K14/47C12N15/11A61K38/16A61P35/00A61P19/02A61P29/00A61P31/14A61P37/08A61P7/06A61P9/10
CPCC07K14/4703A61P35/00A61P19/02A61P29/00A61P31/14A61P37/08A61P7/06A61P9/10A61K38/00
Inventor 胡志远钱怡霞王蔚芝王月华
Owner THE NAT CENT FOR NANOSCI & TECH NCNST OF CHINA